GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
NCT00886626
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Obesity, Morbid
Interventions
DRUG:
Exenatide
Sponsor
University of Minnesota